In humans, Nlrp3 gain-of-function mutations are causing a spectrum of rare auto-inflammatory disorders known as cryopyrin associated periodic syndromes (CAPS). This evidence concerns the gene NLRP3 and cryopyrin-associated periodic syndrome.